--- title: "GPI-led DREAM research project wins €6.2 million Regione Puglia grant" type: "News" locale: "en" url: "https://longbridge.com/en/news/294805265.md" description: "GPI secured a €6.2 million grant from Regione Puglia for the 36-month DREAM research project, which uses AI to study links between Alzheimer’s and Parkinson’s diseases and environmental factors. GPI is allocated EUR 3.5 million of the eligible R&D spending, with Advice Pharma as a partner beneficiary." datetime: "2026-08-04T10:20:14.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294805265.md) - [en](https://longbridge.com/en/news/294805265.md) - [zh-HK](https://longbridge.com/zh-HK/news/294805265.md) generator: "portal-rs" --- # GPI-led DREAM research project wins €6.2 million Regione Puglia grant - GPI secured Regione Puglia funding to launch the 36-month DREAM research project using AI to study Alzheimer’s and Parkinson’s links to environmental factors. \* Total eligible R&D spending is about EUR 6.2 million, including EUR 3.5 million allocated to GPI. \* Advice Pharma is a project partner and beneficiary alongside GPI. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GPI S.p.A. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here ### Related Stocks - [GPI.US](https://longbridge.com/en/quote/GPI.US.md) ## Related News & Research - [Conifer Management Seeks Board Role at Group 1 Automotive with 9.7% Stake](https://longbridge.com/en/news/296533164.md) - [Board Expansion and Dividend Raise New Questions About Group 1 Automotive's Capital Priorities (GPI)](https://longbridge.com/en/news/296564670.md) - [09:56 ETParkinson's Foundation Invests More Than $7.5 Million in Research Grants](https://longbridge.com/en/news/296239828.md) - [Rhelion signs supply license with Toronto’s UHN for psilocybin trial in Parkinson’s depression](https://longbridge.com/en/news/296134949.md) - [Memory: Everyone Puked The Lows. Now They're Chasing The Highs](https://longbridge.com/en/news/296139862.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**